Anelleo, Inc.

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
AnelleO is harnessing the advancements in the speed and scale of 3D printing technology for novel solutions in Women’s Health. Intravaginal Rings (IVR) offer a unique platform for sustained delivery of therapeutics – a non-invasive, self-administered and retrievable platform that can deliver drugs over a period of weeks or months. To-date, IVR technology has been limited to a few successes due to inherent limitations of current manufacturing by injection molding or extrusion. The design flexibility, rapid prototyping, and cost-effective manufacturing of digital light synthesis (DLS) 3D printing allows AnelleO to develop and manufacture IVRs specifically matched to the unique characteristics of the molecule and indication.

AnelleO’s lead product is AnelleO PRO – a self-administered, non-invasive multi-week alternative to daily progesterone supplementation alongside Assisted Reproductive Technologies (ART) for women undergoing fertility treatment.
Ticker:
Not Provided
Exchange:
Not Provided
Company Type:
Not Provided
Company Website:
Not Provided
Company HQ State:
Not Provided
Company HQ Country:
Not Provided
Year Founded:
Not Provided
Main Therapeutic Focus:
Not Provided
Lead Product in Development:
Not Provided
Development Phase of Primary Product:
Not Provided
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Founder & Director
Anelleo, Inc.